Angitia Biopharmaceuticals

About:

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

Website: https://angitiabio.com/

Top Investors: OrbiMed, Hillhouse Ventures, Oriza Holdings, Legend Capital, Morningside Venture Investments

Description:

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.

Total Funding Amount:

$156M

Headquarters Location:

Guangzhou, Guangdong, China

Founded Date:

2018-01-01

Contact Email:

info(AT)angitiabio.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai